Model
Edge
CRISPR Therapeutics
0001708172
Filing Type
4
Filing Date
10/17/2024
Updated
10/18/24, 3:35 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership